| scholarly article | Q13442814 |
| P50 | author | Adi L Tarca | Q88155056 |
| Nandor Gabor Than | Q90970765 | ||
| Petronella Hupuczi | Q92812903 | ||
| Sonia S Hassan | Q96619726 | ||
| Hamutal Meiri | Q114449283 | ||
| Sinuhe Hahn | Q114449284 | ||
| Kata Juhasz | Q114449306 | ||
| Roberto Romero | Q42734915 | ||
| Katalin Paréj | Q84829148 | ||
| Andrea Balogh | Q56257003 | ||
| Offer Erez | Q59705822 | ||
| P2093 | author name string | Zoltan Papp | |
| Eva Pallinger | |||
| Peter Zavodszky | |||
| Simona W Rossi | |||
| Eszter Toth | |||
| Istvan Hajdu | |||
| Janos Matko | |||
| Arpad F Kovacs | |||
| Diana Csala | |||
| Nikolett L Szenasi | |||
| P2860 | cites work | Comparative analysis of decidual and peripheral immune cells and immune-checkpoint molecules during pregnancy in wild-type and PACAP-deficient mice | Q90848759 |
| Immune responses at the maternal-fetal interface | Q91009830 | ||
| Increased placental expression of Placental Protein 5 (PP5) / Tissue Factor Pathway Inhibitor-2 (TFPI-2) in women with preeclampsia and HELLP syndrome: Relevance to impaired trophoblast invasion? | Q91900684 | ||
| A primate subfamily of galectins expressed at the maternal-fetal interface that promote immune cell death | Q24317162 | ||
| Evidence that a human soluble beta-galactoside-binding lectin is encoded by a family of genes | Q24629424 | ||
| Galectins: guardians of eutherian pregnancy at the maternal-fetal interface | Q26823092 | ||
| Galectin-1 research in T cell immunity: Past, present and future | Q26825120 | ||
| Leukocyte driven-decidual angiogenesis in early pregnancy | Q26851470 | ||
| Placental Protein 13 (PP13) - A Placental Immunoregulatory Galectin Protecting Pregnancy | Q26861380 | ||
| A leading role for the immune system in the pathophysiology of preeclampsia | Q27003069 | ||
| Modulation of neutrophil NETosis: interplay between infectious agents and underlying host physiology | Q27693200 | ||
| Galectins: Double-edged Swords in the Cross-roads of Pregnancy Complications and Female Reproductive Tract Inflammation and Neoplasia | Q28081459 | ||
| Tobacco etch virus protease: mechanism of autolysis and rational design of stable mutants with wild-type catalytic proficiency | Q28216587 | ||
| Functional analyses of placental protein 13/galectin-13 | Q28249207 | ||
| Purification and characterization of two new soluble placental tissue proteins (PP13 and PP17) | Q28275001 | ||
| Decidual lymphocytes of human spontaneous abortions induce apoptosis but not necrosis in JEG-3 extravillous trophoblast cells. | Q40701583 | ||
| Changes in T Cell and Dendritic Cell Phenotype from Mid to Late Pregnancy Are Indicative of a Shift from Immune Tolerance to Immune Activation | Q41665214 | ||
| Differential expression of Galectin-1 and Galectin-3 during first trimester human embryogenesis | Q42443034 | ||
| Placenta-derived soluble MHC class I chain-related molecules down-regulate NKG2D receptor on peripheral blood mononuclear cells during human pregnancy: a possible novel immune escape mechanism for fetal survival. | Q42491660 | ||
| Fas ligand mediates activation-induced cell death in human T lymphocytes | Q42942730 | ||
| Interleukin-1 alpha and interleukin-1 beta in preterm and term human parturition | Q44937474 | ||
| Dimeric galectin-1 induces IL-10 production in T-lymphocytes: an important tool in the regulation of the immune response | Q45147481 | ||
| Effects of placental protein 13 on the cardiovascular system in gravid and non-gravid rodents | Q45783688 | ||
| Comparative analysis of maternal-fetal interface in preeclampsia and preterm labor. | Q45985749 | ||
| Apoptosis of T cells mediated by galectin-1. | Q46356564 | ||
| A pivotal role for galectin-1 in fetomaternal tolerance | Q46891030 | ||
| Human Chorionic Gonadotropin as a Pivotal Endocrine Immune Regulator Initiating and Preserving Fetal Tolerance | Q47109145 | ||
| Circulating angiogenic factors and the risk of preeclampsia | Q47217679 | ||
| Recruitment of transferrin receptor to immunological synapse in response to TCR engagement | Q47579077 | ||
| VEGF and VEGFR1 levels in different regions of the normal and preeclampsia placentae | Q47997086 | ||
| Progesterone-induced blocking factor (PIBF) modulates cytokine production by lymphocytes from women with recurrent miscarriage or preterm delivery | Q47997242 | ||
| The role of indoleamine-2,3-dioxygenase in normal and pathological pregnancies | Q48272907 | ||
| Life and Death of Activated T Cells: How Are They Different from Naïve T Cells? | Q49636303 | ||
| Innate lymphoid cells at the human maternal-fetal interface in spontaneous preterm labor | Q49861059 | ||
| The role of decidual immune cells on human pregnancy. | Q50064264 | ||
| The inflammation paradox in the evolution of mammalian pregnancy: turning a foe into a friend | Q50280596 | ||
| Pro- and antiinflammatory cytokines in threatened miscarriages | Q83938012 | ||
| Activated endothelial cells induce neutrophil extracellular traps and are susceptible to NETosis-mediated cell death | Q84391873 | ||
| First‐trimester placental protein 13 and placental growth factor: markers for identification of women destined to develop early‐onset pre‐eclampsia | Q85029222 | ||
| Prediction of preeclampsia by placental protein 13 and background risk factors and its prevention by aspirin | Q87415142 | ||
| Innate and adaptive immune interactions at the fetal-maternal interface in healthy human pregnancy and pre-eclampsia | Q37683540 | ||
| Immune regulation of conception and embryo implantation-all about quality control? | Q37720005 | ||
| Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy | Q37747554 | ||
| Physiologic Uterine Inflammation and Labor Onset: Integration of Endocrine and Mechanical Signals | Q38012004 | ||
| First trimester serum markers to predict preeclampsia | Q38020351 | ||
| Interleukin-6 in pregnancy and gestational disorders | Q38028200 | ||
| Mechanisms of T cell tolerance towards the allogeneic fetus | Q38067209 | ||
| Immune balance at the foeto-maternal interface as the fulcrum of reproductive success | Q38083842 | ||
| Fetomaternal immune cross-talk and its consequences for maternal and offspring's health | Q38104878 | ||
| Galectin signature in normal pregnancy and preeclampsia | Q38129503 | ||
| Understanding the complexity of the immune system during pregnancy. | Q38226317 | ||
| Evolving mechanistic insights into galectin functions | Q38254055 | ||
| Abnormal blood biomarkers in early pregnancy are associated with preeclampsia: a meta-analysis | Q38259145 | ||
| Expression of galectin-1, -3 (gal-1, gal-3) and the Thomsen-Friedenreich (TF) antigen in normal, IUGR, preeclamptic and HELLP placentas | Q38299585 | ||
| Galectins bind to the multivalent glycoprotein asialofetuin with enhanced affinities and a gradient of decreasing binding constants | Q38321186 | ||
| Galectins in angiogenesis: consequences for gestation | Q38333109 | ||
| CD25 blockade protects T cells from activation-induced cell death (AICD) via maintenance of TOSO expression | Q38351173 | ||
| Decidual cytokines and pregnancy complications: focus on spontaneous miscarriage | Q38378099 | ||
| The American College of Obstetricians and Gynecologists Practice Bulletin no. 150. Early pregnancy loss | Q38453417 | ||
| The Paternal Contribution to Fetal Tolerance | Q38547913 | ||
| Molecular Cross-Talk at the Feto-Maternal Interface | Q38589205 | ||
| An immune clock of human pregnancy. | Q38597262 | ||
| To serve and to protect: the role of decidual innate immune cells on human pregnancy | Q38634374 | ||
| Embryo implantation evolved from an ancestral inflammatory attachment reaction | Q38659288 | ||
| Immunological implications of pregnancy-induced microchimerism. | Q38686693 | ||
| The T helper type 17/regulatory T cell paradigm in pregnancy | Q38725966 | ||
| Pathophysiology of preeclampsia: an angiogenic imbalance and long-lasting systemic vascular dysfunction | Q38796954 | ||
| Tim-3: Expression on immune cells and roles at the maternal-fetal interface | Q38803020 | ||
| Placental Protein 13 Administration to Pregnant Rats Lowers Blood Pressure and Augments Fetal Growth and Venous Remodeling | Q38969936 | ||
| HLA-G: At the Interface of Maternal-Fetal Tolerance | Q39171643 | ||
| Galectin-1 influences trophoblast immune evasion and emerges as a predictive factor for the outcome of pregnancy | Q39273203 | ||
| Galectin-1 confers immune privilege to human trophoblast: implications in recurrent fetal loss. | Q39321607 | ||
| Sampling and Definitions of Placental Lesions: Amsterdam Placental Workshop Group Consensus Statement. | Q39737414 | ||
| Up-and-down immunity of pregnancy in humans. | Q40092856 | ||
| Galectin-3 and galectin-1 bind distinct cell surface glycoprotein receptors to induce T cell death | Q40333858 | ||
| The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity | Q28281686 | ||
| Mother's little helpers: mechanisms of maternal-fetal tolerance | Q28297770 | ||
| Orchestration of angiogenesis by immune cells | Q28389236 | ||
| PP13, maternal ABO blood groups and the risk assessment of pregnancy complications | Q28742192 | ||
| Cloning and expression of a novel human galectin cDNA, predominantly expressed in placenta(1). | Q30706429 | ||
| Multimodal Regulation of NET Formation in Pregnancy: Progesterone Antagonizes the Pro-NETotic Effect of Estrogen and G-CSF | Q30830726 | ||
| VEGFR1 and VEGFR2 involvement in extracellular galectin-1- and galectin-3-induced angiogenesis | Q31121321 | ||
| Proteomic analysis on the alteration of protein expression in the placental villous tissue of early pregnancy loss | Q33245316 | ||
| Endocrine factors modulating immune responses in pregnancy | Q33611653 | ||
| Innate immune system and preeclampsia | Q33658840 | ||
| Characteristic Changes in Decidual Gene Expression Signature in Spontaneous Term Parturition | Q33729663 | ||
| The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age. | Q33755648 | ||
| Gestational Diabetes Mellitus Is Associated with Altered Neutrophil Activity | Q33794472 | ||
| Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia | Q33863973 | ||
| Immune surveillance of the maternal/fetal interface: controversies and implications | Q33940662 | ||
| Dysregulated complement activation as a common pathway of injury in preeclampsia and other pregnancy complications | Q33976312 | ||
| Galectinomics: finding themes in complexity | Q34148905 | ||
| Gimme shelter: the immune system during pregnancy | Q34177939 | ||
| Preterm labor: one syndrome, many causes | Q34314824 | ||
| Evolutionary origins of the placental expression of chromosome 19 cluster galectins and their complex dysregulation in preeclampsia | Q34372600 | ||
| Immune cells in term and preterm labor | Q34455630 | ||
| Recent Insight into the Role of the PD-1/PD-L1 Pathway in Feto-Maternal Tolerance and Pregnancy | Q34460789 | ||
| Trophoblast-microbiome interaction: a new paradigm on immune regulation. | Q34496498 | ||
| Normal pregnancy is characterized by systemic activation of the complement system | Q34499492 | ||
| Evolution of non-cytotoxic uterine natural killer cells | Q34590583 | ||
| First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction | Q34647428 | ||
| Neutrophil NETs: a novel contributor to preeclampsia-associated placental hypoxia? | Q34648192 | ||
| IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis | Q34648364 | ||
| HLA Class Ib Molecules and Immune Cells in Pregnancy and Preeclampsia | Q34763454 | ||
| Inflammation and pregnancy: the role of the immune system at the implantation site | Q34806659 | ||
| Natural killer cells and pregnancy | Q34810250 | ||
| Peripheral blood TIM-3 positive NK and CD8+ T cells throughout pregnancy: TIM-3/galectin-9 interaction and its possible role during pregnancy | Q35126662 | ||
| Interleukin-10: a pleiotropic regulator in pregnancy | Q35243821 | ||
| Recurrent Pregnancy Loss through the Lens of Immunology | Q35276432 | ||
| CD8+ effector T cells at the fetal-maternal interface, balancing fetal tolerance and antiviral immunity. | Q37014401 | ||
| Glycobiology simplified: diverse roles of glycan recognition in inflammation | Q37111287 | ||
| Inflammation and pregnancy: the role of toll-like receptors in trophoblast-immune interaction | Q37149772 | ||
| Potential markers of preeclampsia--a review | Q37278804 | ||
| Tolerance to noninherited maternal antigens, reproductive microchimerism and regulatory T cell memory: 60 years after 'Evidence for actively acquired tolerance to Rh antigens'. | Q37337149 | ||
| Severe preeclampsia is characterized by increased placental expression of galectin-1 | Q37416956 | ||
| Placental protein 13 (galectin-13) has decreased placental expression but increased shedding and maternal serum concentrations in patients presenting with preterm pre-eclampsia and HELLP syndrome. | Q37416997 | ||
| Preeclampsia and small-for-gestational age are associated with decreased concentrations of a factor involved in angiogenesis: soluble Tie-2. | Q37428029 | ||
| Galectin-1 functions as a Th2 cytokine that selectively induces Th1 apoptosis and promotes Th2 function | Q37434727 | ||
| Turning 'sweet' on immunity: galectin-glycan interactions in immune tolerance and inflammation | Q37443866 | ||
| First-trimester maternal serum PP13 in the risk assessment for preeclampsia. | Q37444801 | ||
| Microarray profiling reveals that placental transcriptomes of early-onset HELLP syndrome and preeclampsia are similar | Q37567589 | ||
| Immunoregulatory molecules in human placentas: potential for diverse roles in pregnancy | Q37598149 | ||
| Changes of placental syndecan-1 expression in preeclampsia and HELLP syndrome | Q37612423 | ||
| Evidence of an imbalance of angiogenic/antiangiogenic factors in massive perivillous fibrin deposition (maternal floor infarction): a placental lesion associated with recurrent miscarriage and fetal death | Q37612429 | ||
| Activating T regulatory cells for tolerance in early pregnancy - the contribution of seminal fluid | Q37624139 | ||
| Lectins as pattern recognition molecules: the effects of epitope density in innate immunity | Q37638925 | ||
| The role of chemokines in term and premature rupture of the fetal membranes: a review | Q37678741 | ||
| Predicting the Risk to Develop Preeclampsia in the First Trimester Combining Promoter Variant -98A/C of LGALS13 (Placental Protein 13), Black Ethnicity, Previous Preeclampsia, Obesity, and Maternal Age. | Q50879778 | ||
| Binding characteristics of galectin-3 fusion proteins. | Q50944219 | ||
| Placental protein 13 (PP13)-induced vasodilation of resistance arteries from pregnant and nonpregnant rats occurs via endothelial-signaling pathways | Q50992588 | ||
| Maternal lymphocyte subpopulations (CD45RA+ and CD45RO+) in preeclampsia | Q52009983 | ||
| Maternal-fetal cross talk through cell-free fetal DNA, telomere shortening, microchimerism, and inflammation. | Q52632153 | ||
| Impaired Gal-9 Dysregulates the PBMC-Induced Th1/Th2 Imbalance in Abortion-Prone Matings. | Q53279655 | ||
| Activation of villous trophoblastic p38 and ERK1/2 signaling pathways in preterm preeclampsia and HELLP syndrome | Q53639289 | ||
| Changes in the distribution pattern of galectin-1 and galectin-3 in human placenta correlates with the differentiation pathways of trophoblasts | Q53754044 | ||
| Meta-Analysis of Maternal and Fetal Transcriptomic Data Elucidates the Role of Adaptive and Innate Immunity in Preterm Birth | Q55011065 | ||
| Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death | Q56169018 | ||
| Placental Protein 13 and Decidual Zones of Necrosis: An Immunologic Diversion That May be Linked to Preeclampsia | Q56794716 | ||
| Disruption in the Regulation of Immune Responses in the Placental Subtype of Preeclampsia | Q56996369 | ||
| Regulatory T cells in embryo implantation and the immune response to pregnancy | Q57057008 | ||
| Tumor necrosis factor in preterm and term labor. | Q57081409 | ||
| Trained Memory of Human Uterine NK Cells Enhances Their Function in Subsequent Pregnancies | Q57083113 | ||
| Immune Cells at the Fetomaternal Interface: How the Microenvironment Modulates Immune Cells To Foster Fetal Development | Q57260799 | ||
| The anti-inflammatory limb of the immune response in preterm labor, intra-amniotic infection/inflammation, and spontaneous parturition at term: A role for interleukin-10 | Q58417804 | ||
| Antibodies: The major participants in maternal-fetal interaction | Q58588673 | ||
| Clonally Expanded Decidual Effector Regulatory T Cells Increase in Late Gestation of Normal Pregnancy, but Not in Preeclampsia, in Humans | Q58705281 | ||
| Galectin-9 binds IgM-BCR to regulate B cell signaling | Q58770912 | ||
| Galectin-9 suppresses B cell receptor signaling and is regulated by I-branching of N-glycans | Q58771173 | ||
| Human Innate Lymphoid Cells: Their Functional and Cellular Interactions in Decidua | Q58781730 | ||
| Integrated Systems Biology Approach Identifies Novel Maternal and Placental Pathways of Preeclampsia | Q58795465 | ||
| Dynamic changes in maternal decidual leukocyte populations from first to second trimester gestation | Q60793578 | ||
| Identification of a Novel Neutrophil Population: Proangiogenic Granulocytes in Second-Trimester Human Decidua | Q60793580 | ||
| The Role of Extracellular Vesicles and PIBF in Embryo-Maternal Immune-Interactions | Q60956644 | ||
| Neutrophil attractant/activating peptide-1/interleukin-8: association with histologic chorioamnionitis, preterm delivery, and bioactive amniotic fluid leukoattractants | Q61845768 | ||
| Peripheral blood galectin-1-expressing T and natural killer cells in normal pregnancy and preeclampsia | Q63441869 | ||
| Immune Checkpoint Molecules in Reproductive Immunology | Q64102290 | ||
| Placental protein 13 (PP13) stimulates rat uterine vessels after slow subcutaneous administration | Q64112776 | ||
| Mechanisms of growth inhibition by anti-transferrin receptor monoclonal antibodies | Q70126722 | ||
| A progesterone-dependent immunomodulatory protein alters the Th1/Th2 balance | Q71717342 | ||
| Trophoblasts express Fas ligand: a proposed mechanism for immune privilege in placenta and maternal invasion | Q73691401 | ||
| Galectin-1 and -3 in cells of the first trimester placental bed | Q74510168 | ||
| An innate view of human pregnancy | Q77326117 | ||
| Human cell surface glycoprotein related to cell proliferation is the receptor for transferrin | Q35362960 | ||
| Best practice no 178. Examination of the human placenta. | Q35587870 | ||
| First Trimester Pregnancy Loss and the Expression of Alternatively Spliced NKp30 Isoforms in Maternal Blood and Placental Tissue. | Q35669969 | ||
| Macrophages and apoptotic cell clearance during pregnancy | Q35814538 | ||
| Impact of Exogenous Galectin-9 on Human T Cells: CONTRIBUTION OF THE T CELL RECEPTOR COMPLEX TO ANTIGEN-INDEPENDENT ACTIVATION BUT NOT TO APOPTOSIS INDUCTION. | Q35860538 | ||
| Placental oxidative stress: from miscarriage to preeclampsia | Q35879133 | ||
| Tim-3 Is Upregulated in NK Cells during Early Pregnancy and Inhibits NK Cytotoxicity toward Trophoblast in Galectin-9 Dependent Pathway | Q35898865 | ||
| Galectins as self/non-self recognition receptors in innate and adaptive immunity: an unresolved paradox. | Q36093631 | ||
| HLA-G and immune tolerance in pregnancy | Q36109416 | ||
| B7 family molecules as regulators of the maternal immune system in pregnancy | Q36185034 | ||
| Is the trophoblast an immune regulator? The role of Toll-like receptors during pregnancy | Q36259491 | ||
| Evidence of perturbations of the cytokine network in preterm labor | Q36372845 | ||
| Neutrophil NETs in reproduction: from infertility to preeclampsia and the possibility of fetal loss | Q36424780 | ||
| Placental protein 13 (PP13/galectin-13) undergoes lipid raft-associated subcellular redistribution in the syncytiotrophoblast in preterm preeclampsia and HELLP syndrome. | Q36480074 | ||
| The role of regulatory T cells in alloantigen tolerance | Q36563567 | ||
| CXCL10/IP-10: a missing link between inflammation and anti-angiogenesis in preeclampsia? | Q36676660 | ||
| Evidence for a role for the adaptive immune response in human term parturition | Q36692481 | ||
| Genetic communication between fetus and mother: short- and long-term consequences | Q36778092 | ||
| The role of the immune system in preeclampsia | Q36791219 | ||
| Immunology of pregnancy: cellular mechanisms allowing fetal survival within the maternal uterus | Q36802749 | ||
| Neutrophil migration into the placenta: Good, bad or deadly? | Q36857949 | ||
| Dendritic cells: key to fetal tolerance? | Q36862971 | ||
| Regulatory T cells and regulatory natural killer (NK) cells play important roles in feto-maternal tolerance | Q36875737 | ||
| Role of placentally produced inflammatory and regulatory cytokines in pregnancy and the etiology of preeclampsia | Q36875755 | ||
| Tolerance signaling molecules and pregnancy: IDO, galectins, and the renaissance of regulatory T cells. | Q36903097 | ||
| Natural killer (NK) cells from killers to regulators: distinct features between peripheral blood and decidual NK cells | Q36903104 | ||
| Emergence of hormonal and redox regulation of galectin-1 in placental mammals: implication in maternal-fetal immune tolerance | Q36915292 | ||
| Prototype and Chimera-Type Galectins in Placentas with Spontaneous and Recurrent Miscarriages | Q36939136 | ||
| Preeclampsia and angiogenic imbalance | Q36971766 | ||
| Placental pathology: a systematic approach with clinical correlations | Q36976570 | ||
| A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a sma | Q36984261 | ||
| T cell apoptosis at the maternal-fetal interface in early human pregnancy, involvement of galectin-1. | Q36985070 | ||
| Interfering with Gal-1-mediated angiogenesis contributes to the pathogenesis of preeclampsia | Q37010679 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 1240 | |
| P577 | publication date | 2019-06-19 | |
| P1433 | published in | Frontiers in Immunology | Q27723748 |
| P1476 | title | Placental Galectins Are Key Players in Regulating the Maternal Adaptive Immune Response | |
| P478 | volume | 10 |
| Q92320999 | A versatile modular vector set for optimizing protein expression among bacterial, yeast, insect and mammalian hosts |
| Q90113804 | Identification of Structural Variation in Chimpanzees Using Optical Mapping and Nanopore Sequencing |
| Q92142500 | In vitro fertilization and embryo transfer alter human placental function through trophoblasts in early pregnancy |
| Q90164356 | Molecular profiling of an osseous metastasis in glioblastoma during checkpoint inhibition: potential mechanisms of immune escape |
| Q89965744 | Placental Protein 13 (Galectin-13) Polarizes Neutrophils Toward an Immune Regulatory Phenotype |
| Q97521548 | Regulatory T Cells in Pregnancy: It Is Not All About FoxP3 |
Search more.